Cannabics Pharmaceuticals drug shown to have anti-tumor properties

Bethesda-based Cannabics Pharmaceuticals Inc. announced Thursday preliminary findings show that the cannabinoid Cannabigerol (CBG) was shown to have a greater anti-tumor effect on human stomach and bone cancer cell lines compared to CBGA, the acidic form of the compound. The pre-clinical study held at the company's High Throughput Screening (HTS) lab facilities in Israel. CBG is a non-psychoactive cannabinoid found ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *